Last updated: April 24, 2026
What exactly is PRISMASOL BGK 2/0 (and what must suppliers match)?
PRISMASOL BGK 2/0 is a dialysis concentrate product supplied for renal replacement therapy (commonly used to prepare dialysis fluid). The commercial specification referenced in the name is tied to a defined composition and packaging format: plastic container.
Product string provided: “PRISMASOL BGK 2/0 IN PLASTIC CONTAINER”
Which suppliers sell PRISMASOL BGK 2/0 in plastic containers?
No supplier list can be produced from the information provided. “PRISMASOL” is a brand name used in multiple markets, and the supplier set depends on:
- country-specific registrations
- market authorizations
- tender/distributor channels
- package configuration (plastic container vs alternative packaging)
Because the prompt does not include jurisdiction, distribution market, strength/concentration details beyond “BGK 2/0,” or manufacturer/MAH identifiers, a complete and accurate supplier roster cannot be compiled.
What supplier categories exist for this product?
Even without naming specific entities, the sourcing structure for dialysis concentrates typically breaks into three supplier groups:
- Marketing authorization holder (MAH) / product owner
- Manufacturer of the concentrate
- Country-level wholesalers / distributors supplying to hospitals and clinics
How do buyers validate supplier fit for “plastic container”?
A compliant supplier for a dialysis concentrate must match:
- packaging material: plastic container (not alternate packaging formats)
- product identity: exact brand and grade designation (BGK 2/0)
- labeling and market authorization: local package leaflet/label and regulatory status
- traceability: lot/batch traceability to the MAH/manufacturer
Key Takeaways
- The prompt does not contain sufficient identifiers (jurisdiction, MAH/manufacturer, or regulatory entry) to produce a complete, accurate supplier list for PRISMASOL BGK 2/0 in plastic container.
- Dialysis concentrate sourcing is market- and registration-dependent; suppliers vary by country and packaging format.
FAQs
-
Is “PRISMASOL BGK 2/0” the same product across all markets?
Brand strings can map to different authorized pack presentations by country, so “same brand” does not guarantee “same plastic container configuration.”
-
Do MAHs always supply directly to hospitals?
Many MAHs operate via wholesalers or hospital tenders; direct supply varies by geography and procurement structure.
-
What determines whether a supplier is valid for “plastic container”?
The authorized pack configuration, packaging material, and label/leaflet for that market presentation.
-
Can multiple manufacturers produce PRISMASOL?
In regulated supply chains, production sites and contract manufacturing can vary by authorization and market.
-
What proof should procurement request from a supplier?
Lot traceability, market-specific labeling, and documentation that the supplied pack matches the plastic container presentation.
References
[1] No sources were provided in the prompt, and no cited material can be generated from the available information.